Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				17 and over				Pharmaceutical / Industry				EN3267-005 NCT00262678


2.		Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				17 and over				Pharmaceutical / Industry				EN3267-007 NCT00263575


3.		Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioid Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Pharmaceutical / Industry				CPO45/06/FCNS NCT00458510


4.		Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Pharmaceutical / Industry				CPO43/06/FCNS NCT00459277


5.		Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				2006-0961 NCT00542542


6.		A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				20 to 80				Pharmaceutical / Industry				2246-0702 NCT00684632


7.		Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				3 to 15				Pharmaceutical / Industry				C8278b/202/BP/US-CA NCT00236041

Last Modified: 7/9/2007 First Published: 2/17/2006


8.		Randomized Study of Perioperative Epidural Analgesia Versus Patient Controlled Analgesia in Patients Who Have Undergone Surgery for Gynecologic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				Not specified				NCI				UCSF-03423 UCSF-H10588-24197-02, NCT00295945


9.		Regional Anesthesia in Colon Rectal Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 to 85				Other				07-933 NCT00684229

Last Modified: 8/29/2008 First Published: 8/14/2008


10.		Study of Fentanyl Citrate Pharmacokinetics in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis				Active				Adult				NCI				JHOC-J06129 J06129, JHOC-NA-00006329

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute